shortagewatch

Home / Cancer and immune system / Pazopanib

ATC L01EX03 · Antineoplastic Agents

Pazopanib shortage

As of 31 Oct 2026, Pazopanib has a reported shortage in 3 of the 5 countries we track (Germany, Italy, Spain), covering 5 products.

Countries3/5
Products5packs or presentations
Short since1 Apr 20267 months ago
Earliest return9 Dec 2026company estimate
No return date3products
Main reasonIncreased demand
Germany1 pack shortItaly3 packs shortSpain1 pack shortAustriaNo reported shortageBelgiumNo reported shortage

Timeline

GermanyItalySpain
2027Pazopanib Viatris 200 mg FilmtablettenPazopanib Viatris 200 mg FilmtablettenPAZOPANIB SANDOZPAZOPANIB SANDOZPAZOPANIB SANDOZPAZOPANIB SANDOZPAZOPANIB ZENTIVAPAZOPANIB ZENTIVAPAZOPANIB ACCORD 400 MG COMPRIMIDOS RECUBIERPAZOPANIB ACCORD 400 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 60 comprimidostoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
DEPazopanib Viatris 200 mg FilmtablettenViatris Germany GmbH1 Apr 20269 Dec 2026Other
Sonstige
ITPAZOPANIB SANDOZSANDOZ S.P.A.30 May 2026not givenIncreased demand
Elevata richiesta
ITPAZOPANIB SANDOZSANDOZ S.P.A.30 May 2026not givenIncreased demand
Elevata richiesta
ITPAZOPANIB ZENTIVAZENTIVA ITALIA S.R.L.31 Aug 2026not givenManufacturing problem
Problemi produttivi
ESPAZOPANIB ACCORD 400 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 60 comprimidosAccord Healthcare S.L.U.29 Oct 202630 Jan 2027Not stated

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Related medicines also in short supply

Nintedanib Sorafenib Sunitinib